EPW
RGEN icon

Evolve Private Wealth’s Repligen RGEN Stock Holding History

Evolve Private Wealth’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Buy
+3,801
New +$467K 0.03% 503

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Evolve Private Wealth's RGEN Position: Q2 2026 in Review

Evolve Private Wealth opened a new position in Repligen (RGEN) in Q2 2026: 3,801 shares worth $519K. The stake represents 0.03% of the portfolio and ranks #503 among its holdings.

478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Evolve Private Wealth held 3,801 shares of Repligen worth $519K as of Q2 2026.
  • Repligen was a new Evolve Private Wealth position in Q2 2026.
  • Repligen made up 0.03% of Evolve Private Wealth's portfolio in Q2 2026, its #503 holding.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.